Theranos

Theranos Voids Two Years of Test Results

Theranos Voids Two Years of Test Results
Image credit: Reuters | Brendan McDermid
Elizabeth Holmes, CEO of Theranos.
2 min read
This story originally appeared on Reuters

Blood-testing firm Theranos Inc. notified the U.S. federal health regulators that it voided results from its Edison blood-testing devices for two years, the Wall Street Journal reported on Wednesday, citing a person familiar with the matter.

The company informed the Centers for Medicare and Medicaid Services that it has issued tens of thousands of corrected blood-test reports to doctors and patients, nullifying some results and revising others, the Journal reported, citing a person familiar with the matter.

The corrected reports include the Edison results and many tests run on traditional laboratory machines, the Journal said.

"... We've taken comprehensive corrective measures to address the issues CMS raised in their observations. As these matters are currently under review, we have no further comment at this time," a Theranos spokeswoman said in an email.

In April, U.S. federal health regulators had proposed banning the company's founder, Elizabeth Holmes, from the blood-testing business for at least two years after determining that the company failed to fix deficiencies at its California laboratory.

The blood-testing firm which expanded its board to include Dr. Fabrizio Bonanni, a former Amgen Inc. and Baxter International Inc. executive, has been under investigation by several U.S. regulators in the recent past.

Centers for Medicare and Medicaid Services was not immediately available for comment.

(Reporting by Vishal Sridhar in Bengaluru; Editing by Sunil Nair)

My Queue

There are no Videos in your queue.

Click on the Add to next to any video to save to your queue.

There are no Articles in your queue.

Click on the Add to next to any article to save to your queue.

There are no Podcasts in your queue.

Click on the Add to next to any podcast episode to save to your queue.

You're not following any authors.

Click the Follow button on any author page to keep up with the latest content from your favorite authors.

How a $9 Billion Startup Deceived Silicon Valley